Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Altimmune, Inc. (ALT)

4.82   -0.02 (-0.41%) 05-19 22:31
Open: 4.79 Pre. Close: 4.84
High: 5 Low: 4.565
Volume: 785,200 Market Cap: 208(M)
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.01 - 5.04 5.04 - 5.06
Low: 4.5 - 4.53 4.53 - 4.56
Close: 4.77 - 4.83 4.83 - 4.87

Technical analysis

as of: 2022-05-19 4:21:15 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 6.51     One year: 7.61
Support: Support1: 4.49    Support2: 3.82
Resistance: Resistance1: 5.57    Resistance2: 6.51
Pivot: 4.59
Moving Average: MA(5): 4.98     MA(20): 4.58
MA(100): 6.61     MA(250): 9.81
MACD: MACD(12,26): -0.2     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 75.3     %D(3): 77.5
RSI: RSI(14): 48.4
52-week: High: 19.45  Low: 3.82
Average Vol(K): 3-Month: 867 (K)  10-Days: 729 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ALT ] has closed below upper band by 34.5%. Bollinger Bands are 9.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 19 May 2022
Google adding Gmail alt-text support, Meet multipin, and more for Android 13 Talkback - 9to5Google

Thu, 19 May 2022
MAAP Alt Road Cargo bib shorts review - Cyclingnews

Thu, 19 May 2022
ADC partners with Alt Magic to launch the first WebXR Cannabis Store in Metaverse - GlobeNewswire

Thu, 19 May 2022
Premiere: Emerging Alt-R&B Talent Rio Rainz Spirals Out Of Control In “Damaged” Video - Complex

Thu, 19 May 2022
5 hidden costs of working with alt data - CIO

Thu, 19 May 2022
Revolutionary Alt-History Title Steelrising Gets a Cinematic New Story Trailer - Push Square

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 43 (M)
% Held by Insiders 3.559e+007 (%)
% Held by Institutions 5.4 (%)
Shares Short 4,140 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -8.429e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 923.7
Return on Equity (ttm) -22.9
Qtrly Rev. Growth 4.41e+006
Gross Profit (p.s.) 30.88
Sales Per Share -33.85
EBITDA (p.s.) -5.14296e+007
Qtrly Earnings Growth -2.4
Operating Cash Flow 0 (M)
Levered Free Cash Flow -78 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.15
Price to Cash Flow 1.33

Stock Dividends

Dividend 0
Forward Dividend 2.84e+006
Dividend Yield 0%
Dividend Pay Date 2018-09-13
Ex-Dividend Date 2017-01-19
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.